AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Foresight Autonomous Holdings Ltd.

Foreign Filer Report Jan 4, 2025

6793_rns_2025-01-03_ef9c9f20-3053-499f-b620-5dcdb74e2a69.pdf

Foreign Filer Report

Open in Viewer

Opens in native device viewer

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

For the month of: January 2025

Commission file number: 001-38094

FORESIGHT AUTONOMOUS HOLDINGS LTD.

(Translation of registrant's name into English)

7 Golda Meir

Ness Ziona 7403650 Israel (Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40- F.

Form 20-F ☒ Form 40-F ☐

CONTENTS

On December 31, 2024, Foresight Autonomous Holdings Ltd. (the "Registrant") increased the maximum aggregate offering price of American Depositary Shares (the "ADSs"), each ADS representing thirty ordinary shares, issuable under its Sales Agreement (the "Sales Agreement") with A.G.P./Alliance Global Partners, dated June 14, 2024, from \$1,130,000 to \$7,000,000. A copy of the opinion of Lipa Meir & Co. relating to the legality of the issuance and sale of the ADSs that may be sold pursuant to the Sales Agreement is attached as Exhibit 5.1 hereto.

This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the Registrant's Registration Statements on Form F-3 (File No. 333-276709) and Form S-8 (Registration Nos. 333-229716, 333- 239474, 333-268653 and 333-280778), filed with the Securities and Exchange Commission, to be a part thereof from the date on which this Report of Foreign Private Issuer on Form 6-K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

Exhibit No. Description
5.1 Opinion of Lipa Meir & Co.
23.1 Consent of Lipa Meir & Co. (contained in Exhibit 5.1).
104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Foresight Autonomous Holdings Ltd. (Registrant)

Date: January 3, 2025 By: /s/ Eli Yoresh

Name: Eli Yoresh Title: Chief Financial Officer

Exhibit 5.1

PAMEI
R CO.IL
ד"ר ליפא מאיר רושי אייז עדי ערמן יובל חדד YUVAL HADAD ADI ARMAN ROY AIZ R. LIPA MEIR
צוריאל לריא ורד זליכה נועה וקסברגר טעה מוזס NOA MOZES NOA WACHSBERGER VERED ZI AIKHA URIFI LAVIE
אלון פומרנץ יוסי מודלראוח רימון דיין שיר טפרברג SHIR TEPERBERG RIMON DAYAN YOSSI MANDEI BAUM LON POMERANC
עוזי מור שמרית כרמי-נעמת ישי לבנון עופרי לנדסמן OFRITANDESMAN ISHAY LEVANON SHIMRIT CARMY NAAMAT IZI MOR
גרי קופלוביץ עומר מאירי שחף רוט-קליין מיכל דלויה MICHAL DALOYA SHAHAF ROTH-KI FIN OMER MEIRI ARY COPELOVITZ
גד אזור אלעד שולמו עידו זבורוף דור לרה DOR I ABA IDO ZABOROF FI AD SHUI MAN AD AZOR
אח דר לולו קרנית אקריש צחי משעל למא יאור I AMA YAWIR TSAHI MISHAL KARNIT AKRISH REZ DAR LUI U
יריב שלום יערה פרוינד-אברהם וול מזרנ קורין כהן אלחנני KORIN COHEN ELHANANI TAL MORAG YAARA FRUEND-AVRAHAM ARIV SHALOM
ד"ר זיו פרייז (1) גרגורי אירגו אור שלמה נבו רוני גינצרורג RONNY GINSBURG OR SHI OMO NEVO GREGORY IRGO R. ZIV M. PREIS (I)
מיכל שורץ טל גרוות מוריה ומרחי אליזרט שכטמייסטר FUZABETH SHAHTMAYSTER MORIA MIZRAHI TAI GRANOT ICHAI SCHWARTZ
שבתאי מיכאלי שוקי לוי שיר דיגמי-טל SHIR DIGMI-TAL SHUKI LEVI HABTAI MICHAELI
איתן שמואלי יצחק אנידגר צח כהן TZAH COHEN ISAAC ANIDJAR ITAN SHMUELI
אמיר זולטי דור ארינרי עדן רביבו EDEN REVIVO DOR AVINERY MIR ZOLTY
ארז תיק איילת רח מאור זילכה MAOR ZII KA AYFIFT RAM REZ TIK
שירלי יפרח-אזור רעות בייץ ול פרי TAI PERI REUT BEITZ HIRLEY IFRACH-AZOR
ד"ר ציפי איסר איציק ניר מנחם רעות שאולי REUT SHAULI NIR MENAHEM R. TZIPI ISER ITSIQ
גלי אופינסקי לילך הוק אורלי אקרשטיין ORLY ACKERSTEIN I II ACH HOFK ALLOPINSKY
דוד וינשטיין רווה הויג אור רר גור OR BAR GUR RONA HENIG AVID WEINSTEIN
ד"ר יריב אילן גיא משולם רביד טיב ישי RAVID TIV ISHAI GUY MESHUI AM R. YARIV ILAN
מאיר אלבוים יוני שטינמץ חומזגני איל חיאט EYAL KHAYAT HEN MAZGANI YONI SHTAINMETZ IEIR ELBAUM
טלי לב (II) (II) אלה בן-דור עורר מויוגר יול רונן בהרב RONEN BAHARAV INBAR MENINGER JUHI FILA BEN-DOR ALI LEV (IV(II)
סילריה גל-יהר טל אסולין-מנחמוב וטלי ושרא ד"ר יהודה בן מאיר (III) DR. YEHUDA BEN-MEIR (III) NATALIE SHVA TAL ASUI IN-MENAHEMOV YLVIA GAL-YAHAV
שי תמר שגיא אגמון הדס אסולין קנדיל ד"ר אירית מבורך (II) DR. IRIT MEVORACH (III) HADAS ASULIN KANDIL SAGI JAY AGMON HAY TAMAR

December 31, 2024

To:

Foresight Autonomous Holdings Ltd. 7 Golda Meir St. Ness Ziona 7403650 Israel

Re: Proposed Offering of American Depository Shares

Ladies and Gentlemen,

We have acted as Israeli counsel to Foresight Autonomous Holdings Ltd., a company organized under the laws of the State of Israel (the "Company"), in connection with the proposed offer and sale by the Company, from time to time, of a maximum aggregate offering price of up to \$7,000,000 of American Depositary Shares (the "Offered ADSs"), each representing thirty (30) ordinary shares, no par value per share, of the Company (the "Ordinary Shares"), which may be issued and sold by the Company from time to time on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, as amended (the "Securities Act"), pursuant to a registration statement on Form F-3 (Registration Statement No. 333-276709) (the "Registration Statement") filed with the United States Securities and Exchange Commission (the "SEC") under the Securities Act, the prospectus supplement dated June 14, 2024, and the prospectus supplement dated December 31, 2024 (collectively, the "Prospectus Supplement"), filed with the SEC pursuant to Rule 424(b) of the rules and regulations of the Securities Act and as to which this opinion is filed as an exhibit. This opinion is being rendered in connection with the proposed offering and sale by the Company of the ADSs pursuant to the terms of a Sales Agreement dated June 14, 2024 entered into between the Company and A.G.P./Alliance Global Partners (the "Sales Agreement").

In connection with this opinion, we have examined the originals, or photocopies or copies, certified or otherwise identified to our satisfaction, of (i) a copy of the articles of association of the Company as currently in effect (the "Articles"); (ii) resolutions of the board of directors (the "Board") of the Company which have heretofore been approved and which relate to the Registration Statement, the Prospectus Supplement and the actions to be taken in connection therewith; and (iii) such other corporate records, agreements, documents and other instruments as we have deemed relevant and necessary as a basis for the opinions hereafter set forth.

In such examination, we have assumed: (i) the authenticity of original documents and the genuineness of all signatures; (ii) the conformity to the originals of all documents submitted to us as copies; (iii) the truth, accuracy and completeness of the information, representations and warranties contained in the corporate records, documents, certificates and instruments we have reviewed; (iv) the due execution and delivery of all documents where due execution and delivery are a prerequisite to the effectiveness thereof; and (v) the legal capacity of all natural persons.

PERSONAL. PROFESSIONAL. CREATIVE

- 2 -

On the basis of the foregoing, and in reliance thereon, we are of the opinion that the Ordinary Shares underlying the Offered ADSs have been duly authorized by the Company, and, when issued and paid for in accordance with the terms and conditions of the Sales Agreement, will be validly issued, fully paid and non-assessable.

We are members of the Israel Bar and we express no opinion as to any matter relating to the laws of any jurisdiction other than the laws of the State of Israel and have not, for the purpose of giving this opinion, made any investigation of the laws of any other jurisdiction than the State of Israel. This opinion is limited to the matters stated herein and no opinion is implied or may be inferred beyond the matters expressly stated.

We hereby consent to the filing of this opinion as an exhibit to the Report of Foreign Private Issuer on Form 6-K of the Company being filed on the date hereof and to the reference to our firm in the Prospectus Supplement. In giving such consent, we do not believe that we are "experts" within the meaning of such term as used in the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission issued thereunder with respect to any part of the Registration Statement, including this opinion as an exhibit or otherwise.

Very truly yours,

/s/ Lipa Meir & Co. Lipa Meir & Co.

Talk to a Data Expert

Have a question? We'll get back to you promptly.